NFE2L2, a crucial transcription factor involved in oxidative stress responses, is often mutated in non-HBV HCC, but not in HBV-infected tumors when comparing the somatic mutation profiles of HBV and non-HBV HCC. Here, NFE2L2 is linked to hepatocellular carcinoma.